Back to Chinese Version  
Location :HOME > Company Introduction

Grand Yangtze Capital is an investment firm focused principally on equity investments in growth and expansion stage enterprises in China. We have been managing 7 PE and VC funds since 2007 and have deployed over 4 billion RMB. 

Grand Yangtze Capital has invested in over 40 companies, among which 8 companies went public, and several others were merged or acquired, e.g. Sino-Crystal (300064), Shuanghuan(002472), Hainan Rubber(601118), HLBN(300291), ZMJ(601717), China UMS, ZBT Pharma, ELLASSAY(603808), B-Soft(300451), Guochuang Software(300520), YMatou, Pharma Block, etc. 

We have been named as one of the top equity investment funds in China by Zero2IPO (a leading integrated information & service provider in         China's private equity industry) as well as other well known business media and investment associations:

-One of the Top 30 PE Institutes (Domestic) by Zero2IPO in 2010 and 2011
-PE with Greatest Growth Potential Award by <21st Century Business Herald> in 2012
-One of the Top 50 PE Institutes (Domestic) by Zero2IPO in 2013
-One of the Top 5 PE Funds with Best Return by China Private Equity Investor Association in 2014

Our core team members have been working together for over 8 years.  The team collectively has deep experience across operations and invest-   ments, with an average of over 12 years of operating and investment experience. 

Our Vision:

To become one of the most trusted and respected equity investment firms in China, to be able to create great value for our portfolio companies   and to generate superior returns for our investors

Our Mission:

To assist our portfolio companies to become industry leaders with not only our capital, but also our value-added services stemming from in-depth industry expertise, connections, resources and business wisdom

Key Values: